SUPERNUS PHARMACEUTICALS, INC.
20 transactions · Newest trade first
Accepted in the last 30 daysNo qualifying insider buying. No qualifying insider sales.
Filing activity uses public SEC acceptance timestamps. The qualifying-buys metric above uses trade dates at the snapshot cutoff.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberSupernus Pharmaceuticals, Inc. - Common Stock (SUPN) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberSupernus Pharmaceuticals, Inc. - Common Stock (SUPN) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House member